Alto Neuroscience (ANRO) Treasury Shares (2023 - 2025)
Alto Neuroscience (ANRO) reported Treasury Shares of $27000.0 for Q4 2025, down 50.0% on a YoY basis from $54000.0 in Q4 2024, and little changed sequentially from $27000.0 in Q3 2025.
Alto Neuroscience (ANRO) Treasury Shares (2023 - 2025) Analysis & Trends
Alto Neuroscience (ANRO) has 3 years of Treasury Shares data on file, last reported at $27000.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares fell 50.0% year-over-year to $27000.0; the trailing twelve-month figure through Dec 2025 stood at $27000.0 (down 50.0% YoY), and the FY2025 full-year result was $27000.0, down 50.0% from the prior year.
- Treasury Shares was little changed at $27000.0 in Q4 2025, from $27000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $29.9 million in Q4 2023 to a low of $27000.0 in Q3 2025.
- A 3-year average of $13.0 million and a median of $20.4 million in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slumped 99.82% in 2024 and slumped 50.0% in 2025, its largest moves.
- Tracing ANRO's Treasury Shares over 3 years: stood at $29.9 million in 2023, then tumbled by 99.82% to $54000.0 in 2024, then tumbled by 50.0% to $27000.0 in 2025.
- Business Quant data shows ANRO's Treasury Shares at $27000.0 in Q4 2025, $27000.0 in Q3 2025, and $54000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Alto Neuroscience | 881.86 Mn | 881.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 29.92 Mn |
| Dec 31, 2023 | 29.92 Mn |
| Sep 30, 2023 | 20.37 Mn |
| Sep 30, 2023 | 20.37 Mn |
| Jun 30, 2023 | 20.37 Mn |
| Jun 30, 2023 | 20.37 Mn |
| Mar 31, 2023 | 20.37 Mn |
| Mar 31, 2023 | 20.37 Mn |